Hon Kit Wong
YOU?
Author Swipe
View article: Ergonomic challenges and barriers of robotic surgery—a review
Ergonomic challenges and barriers of robotic surgery—a review Open
View article: Data from Anti–Vascular Endothelial Growth Factor Therapies as a Novel Therapeutic Approach to Treating Neurofibromatosis-Related Tumors
Data from Anti–Vascular Endothelial Growth Factor Therapies as a Novel Therapeutic Approach to Treating Neurofibromatosis-Related Tumors Open
Patients with bilateral vestibular schwannomas associated with neurofibromatosis type 2 (NF2) experience significant morbidity such as complete hearing loss. We have recently shown that treatment with bevacizumab provided tumor stabilizati…
View article: Supplementary Figure 1 from Anti–Vascular Endothelial Growth Factor Therapies as a Novel Therapeutic Approach to Treating Neurofibromatosis-Related Tumors
Supplementary Figure 1 from Anti–Vascular Endothelial Growth Factor Therapies as a Novel Therapeutic Approach to Treating Neurofibromatosis-Related Tumors Open
Supplementary Figure 1 from Anti–Vascular Endothelial Growth Factor Therapies as a Novel Therapeutic Approach to Treating Neurofibromatosis-Related Tumors
View article: Data from Anti–Vascular Endothelial Growth Factor Therapies as a Novel Therapeutic Approach to Treating Neurofibromatosis-Related Tumors
Data from Anti–Vascular Endothelial Growth Factor Therapies as a Novel Therapeutic Approach to Treating Neurofibromatosis-Related Tumors Open
Patients with bilateral vestibular schwannomas associated with neurofibromatosis type 2 (NF2) experience significant morbidity such as complete hearing loss. We have recently shown that treatment with bevacizumab provided tumor stabilizati…
View article: Supplementary Figure 1 from Anti–Vascular Endothelial Growth Factor Therapies as a Novel Therapeutic Approach to Treating Neurofibromatosis-Related Tumors
Supplementary Figure 1 from Anti–Vascular Endothelial Growth Factor Therapies as a Novel Therapeutic Approach to Treating Neurofibromatosis-Related Tumors Open
Supplementary Figure 1 from Anti–Vascular Endothelial Growth Factor Therapies as a Novel Therapeutic Approach to Treating Neurofibromatosis-Related Tumors
View article: Additional file 3: Table S4. of Dissecting the role of non-coding RNAs in the accumulation of amyloid and tau neuropathologies in Alzheimerâ s disease
Additional file 3: Table S4. of Dissecting the role of non-coding RNAs in the accumulation of amyloid and tau neuropathologies in Alzheimerâ s disease Open
Reported are the p-value and beta coefficient for the association of each lincRNA with AD, NP and NFT from a series of linear models which include Study, Age at death, Sex, neuronal proportion (NNLS), post-mortem interval (PMI) and RNA Int…
View article: Additional file 2: Table S2. of Dissecting the role of non-coding RNAs in the accumulation of amyloid and tau neuropathologies in Alzheimer’s disease
Additional file 2: Table S2. of Dissecting the role of non-coding RNAs in the accumulation of amyloid and tau neuropathologies in Alzheimer’s disease Open
A table to assess whether the various demographic and neuro-pathological variables may be confounding the relationship between miRNA expression and pathological AD. A linear model is used to model miRNA expression by Study, Age at death, S…